Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

ArkBio has concluded enrolment and dosing for a Phase I trial of AK0610, to prevent RSV infection, particularly in vulnerable ...

(“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a ...

Scripps Research scientists engineered stable RSV and hMPV F proteins, overcoming instability challenges to design effective ...

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...

AT-02 is a fusion protein of humanized immunoglobulin G1 with a pan amyloid-reactive peptide that facilitates binding of the antibody to amyloid deposits and subsequent removal. The Food and Drug ...

This valuable study advances our understanding of how Nipah virus fusion protein F (NiV-F) organizes into nanoclusters on cell and viral membranes using biochemical and super-resolution microscopy ...